Medicare Drug Moves

February 2003
njbiz;2/3/2003, Vol. 16 Issue 5, p5
Focuses on the Medicare drug benefit plan of U.S. President George W. Bush. Proposed spending for Medicare; Proposal of the pharmaceutical industry in regard to the plan; Concern of the Republican Party on the plan.


Related Articles

  • US Medicare reform: why drug companies and private insurers are smiling. Hurley, Jeremiah; Morgan, Steve // CMAJ: Canadian Medical Association Journal;2/17/2004, Vol. 170 Issue 4, p461 

    Focuses on the benefits of a reform in the U.S. Medicare signed President George W. Bush to the pharmaceutical industry and private insurers. Overview of a prescription-drug benefit for senior citizens; Actions taken to make the plan sufficiently tempting to patients with modest drug costs and...

  • The Other War on Drugs.  // njbiz;10/28/2002, Vol. 15 Issue 44, p2 

    Reports on the announcement of U.S. President George W. Bush which called for restricting the legal tactics that brand-name drug companies often use to block competition from generic versions of their products in 2002. Views on a rule on the right of companies to obtain multiple, automatic...

  • Remarks Following a Visit to Ferris Hills at West Lake Senior Center in Canandaigua. Bush, George W. // Weekly Compilation of Presidential Documents;3/20/2006, Vol. 42 Issue 11, p471 

    Presents a speech by U.S. President George W. Bush delivered at West Lake Senior Center in Canandaigua, New York on March 14, 2006. Discussion on the Medicare Prescription Drug Benefit; Acknowledgement of the efforts of Thompson Health Care Group to promote the Medicare program; Benefits of the...

  • Remarks Following a Meeting on Medicare Prescription Drug Benefits. Bush, George W. // Weekly Compilation of Presidential Documents;4/30/2007, Vol. 43 Issue 17, p511 

    The article presents a speech by U.S. President George W. Bush following a meeting on Medicare prescription drug benefits. He says they reformed Medicare and gave seniors a lot of choices. After the plan is in place, the president claims drug costs are less than anticipated and the cost to the...

  • Progress slow in Medicare reform efforts. Frederick, Jim // Drug Store News;8/13/2007, Vol. 29 Issue 10, p55 

    The article discusses issues related to the slow progress of the reform efforts made by legislators to the Medicare Modernization Act of 2003 (MMA), the law that created the Part D benefit in the U.S. The administration of President George W. Bush argued in a veto threat that giving Medicare the...

  • Careless. Cohn, Jonathan // New Republic;12/15/2003, Vol. 229 Issue 24, p17 

    The author argues that, while the Medicare reform law signed by U.S. President George W. Bush appears to expand Medicare, it may actually send Medicare into a death spiral. While the reform law certainly expands government--to the tune of $400 billion over the first ten years--its fundamental...

  • For drug makers, Bush spells relief. Sherrid, Pamela // U.S. News & World Report;02/05/2001, Vol. 130 Issue 5, p39 

    Focuses on the relationship between United States President George W. Bush and the pharmaceutical industry. Perceived challenges posed to the industry by the inclusion of a prescription drug benefit in Medicare; Speculation regarding the possibility of closer governmental scrutiny of drug...

  • Feds propose punishing those who charge more.  // Drug Topics;1/12/2004, Vol. 148 Issue 1, p10 

    Reports that President George W. Bush's Administration has proposed a policy that would punish pharmacies, hospitals and other healthcare providers that charge Medicare or Medicaid substantially more that they usually charge private insurers. Allowable charges; Punishment for violators.

  • TOP STORIES.  // MondayMorning;9/24/2007, Vol. 15 Issue 38, p1 

    The article reports that the U.S. Congress has sent U.S. President George W. Bush legislation which provides the government with more power to police the safety of prescription drugs. The legislation grants the Food and Drug Administration (FDA) authority to make pharmaceutical companies study...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics